Startups
APIM Therapeutics

APIM Therapeutics

https://apimtherapeutics.com

APIM Therapeutics is developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen).

Summary

Seedtable Score
  • 12
Locations
Company Size
  • 1 to 10 employees
Last Stage Round
  • Unknown
Industry

Total funding Amount

$3M

Fundraising History

Investors